Life Healthcare Group Holdings Ltd
OTC:LTGHY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (9.8), the stock would be worth $1.56 (47% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 18.4 | $2.93 |
0%
|
| 3-Year Average | 9.8 | $1.56 |
-47%
|
| 5-Year Average | 9.8 | $1.56 |
-47%
|
| Country Average | 13 | $2.06 |
-30%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
$17.3B
|
/ |
Oct 2025
976m
|
= |
|
|
$17.3B
|
/ |
Sep 2026
4.2B
|
= |
|
|
$17.3B
|
/ |
Sep 2027
4.7B
|
= |
|
|
$17.3B
|
/ |
Sep 2028
5.1B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| ZA |
L
|
Life Healthcare Group Holdings Ltd
OTC:LTGHY
|
18B USD | 18.4 | 4.7 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
108.2B USD | 9.5 | 15.9 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 31.9 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
24B ZAR | 9.4 | 14.3 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
78.2B MYR | 15.3 | 37.2 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
85.3B BRL | 7.8 | 18.2 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.4B USD | 5.7 | 11.7 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
97.1B CNY | 21.4 | 30.2 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 30 | 61.9 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
11.1B USD | 5.7 | 7.4 | |
| ID |
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
186T IDR | 2 284.7 | -934.8 |
Market Distribution
| Min | 1.7 |
| 30th Percentile | 10.7 |
| Median | 13 |
| 70th Percentile | 13 |
| Max | 1 092.3 |
Other Multiples
Life Healthcare Group Holdings Ltd
Glance View
Life Healthcare Group Holdings Ltd. is a significant player in the healthcare industry, predominantly operating in South Africa and with expanding interests in the United Kingdom and Western Europe. Established with the aim of providing world-class medical care, the company has grown from a single hospital operation into a diversified group. Its business model is primarily centered around the management and ownership of acute care hospitals. These hospitals cater to a wide range of medical needs, from emergency care and planned surgeries to specialist-led treatments for chronic conditions. By continually investing in state-of-the-art medical technology and innovative care practices, Life Healthcare ensures that its facilities remain at the forefront of medical excellence. Through its integrated network of healthcare services, the company serves both privately insured and state-insured patients, creating multiple revenue streams that bolster its financial stability. Beyond its hospital operations, Life Healthcare has strategically diversified into adjacent areas, notably in diagnostics and mental health services. By acquiring and integrating imaging service providers in Europe, the company has tapped into the growing market for radiology and diagnostics, which widens its service offerings and generates additional revenue. Furthermore, their expansion into mental health underscores a commitment to addressing the full spectrum of healthcare needs. This approach not only enhances patient care but also opens new avenues for growth as demand for these services increases globally. The company's ability to generate revenue through both its core hospital operations and its expanding healthcare services positions it as a robust and adaptive player in the evolving healthcare landscape.